Literature DB >> 35716172

Bioscreening and pre-clinical evaluation of the impact of bioactive molecules from Ptychotis verticillata on the multilineage potential of mesenchymal stromal cells towards immune- and inflammation-mediated diseases.

Fatima Bouhtit1,2, Mehdi Najar3,4,5, Laurence Lagneaux6, Makram Merimi1,2, Saida Rahmani1,2, Rahma Melki2, Mustapha Najimi7, Khalid Sadki8, Noreddine Boukhatem2, Jean-Claude Twizere9,10, Nathalie Meuleman1, Philippe Lewalle1.   

Abstract

OBJECTIVE AND
DESIGN: Mesenchymal stromal cells (MSCs) are currently used in cell reparative medicine due to their trophic and ant-inflammatory properties. The modulation of stem cell properties by phytochemicals has been suggested as a tool to empower their tissue repair capacity. In vitro, MSCs are characterized by their tri-lineage potential that holds great interest for tissue regeneration. Ptychotis Verticillata (PV), an aromatic and medicinal plant, may be thus used to modulate the in vitro multilineage potential of MSCs.
MATERIALS AND METHODS: We screened the impact of PV-derived essential oil and their bioactive molecules (thymol and carvacrol) on the in vitro multilineage potential of MSCs. Different concentrations and incubation times of these compounds were assessed during the osteogenesis and adipogenesis of MSCs.
RESULTS: The analysis of 75 conditions indicates that these compounds are biologically active by promoting two major differentiation lineages from MSCs. In a time- and dose-dependent manner, thymol and carvacrol increased the osteogenesis and adipogenesis.
CONCLUSION: According to these preliminary observations, the addition of PV extract may stimulate the tissue regenerative and repair functions of MSCs. Further optimization of compound extraction and characterization from PV as well as cell treatment conditions should increase their therapeutic value in combination with MSCs.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Essential oil; MSCs; Medicinal plants; Multilineage potential; Reparative medicine; Thymol and carvacrol

Mesh:

Substances:

Year:  2022        PMID: 35716172     DOI: 10.1007/s00011-022-01573-3

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   6.986


  48 in total

Review 1.  Mesenchymal stromal cell 'licensing': a multistep process.

Authors:  M Krampera
Journal:  Leukemia       Date:  2011-05-27       Impact factor: 11.528

Review 2.  Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.

Authors:  Ying Wang; Xiaodong Chen; Wei Cao; Yufang Shi
Journal:  Nat Immunol       Date:  2014-11       Impact factor: 25.606

3.  Immunological modulation following bone marrow-derived mesenchymal stromal cells and Th17 lymphocyte co-cultures.

Authors:  Mehdi Najar; Hussein Fayyad-Kazan; Wissam H Faour; Makram Merimi; Etienne M Sokal; Catherine A Lombard; Hassan Fahmi
Journal:  Inflamm Res       Date:  2018-11-30       Impact factor: 4.575

Review 4.  Thymol, thyme, and other plant sources: Health and potential uses.

Authors:  Bahare Salehi; Abhay Prakash Mishra; Ila Shukla; Mehdi Sharifi-Rad; María Del Mar Contreras; Antonio Segura-Carretero; Hannane Fathi; Nafiseh Nasri Nasrabadi; Farzad Kobarfard; Javad Sharifi-Rad
Journal:  Phytother Res       Date:  2018-05-22       Impact factor: 5.878

5.  Profiling polyphenol composition by HPLC-DAD-ESI/MSn and the antibacterial activity of infusion preparations obtained from four medicinal plants.

Authors:  Borhane E C Ziani; Lillian Barros; Ali Z Boumehira; Khaldoun Bachari; Sandrina A Heleno; Maria Jose Alves; Isabel C F R Ferreira
Journal:  Food Funct       Date:  2018-01-24       Impact factor: 5.396

Review 6.  Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering.

Authors:  Stephen M Richardson; Judith A Hoyland; Reza Mobasheri; Constanze Csaki; Mehdi Shakibaei; Ali Mobasheri
Journal:  J Cell Physiol       Date:  2010-01       Impact factor: 6.384

7.  Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges.

Authors:  Mehdi Najar; Fatima Bouhtit; Rahma Melki; Hassan Afif; Abdellah Hamal; Hassan Fahmi; Makram Merimi; Laurence Lagneaux
Journal:  J Clin Med       Date:  2019-05-08       Impact factor: 4.241

Review 8.  Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.

Authors:  Matthew B Murphy; Kathryn Moncivais; Arnold I Caplan
Journal:  Exp Mol Med       Date:  2013-11-15       Impact factor: 8.718

9.  Rethinking regeneration: empowerment of stem cells by inflammation.

Authors:  Y Shi; J Cao; Y Wang
Journal:  Cell Death Differ       Date:  2015-12       Impact factor: 15.828

Review 10.  In vitro Culture of Naïve Human Bone Marrow Mesenchymal Stem Cells: A Stemness Based Approach.

Authors:  Bidisha Pal; Bikul Das
Journal:  Front Cell Dev Biol       Date:  2017-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.